Reply to “A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned”
John R. Dimar II, Steven D. Glassman, J. Kenneth Burkus, Philip W. Pryor, James W. Hardacker, Leah Y. CarreonVolume:
11
Year:
2011
Language:
english
DOI:
10.1016/j.spinee.2011.09.029
File:
PDF, 71 KB
english, 2011